
Dyne Therapeutics (DYN) Earnings Dates & Reports
Dyne Therapeutics (DYN) Most Recent Earnings
Report DateNov 5, 2025
Period EndingQ3 2025
Est. EPS-$0.83
Actual EPS-$0.76
EarningsBeat
Dyne Therapeutics (DYN) Earnings
View the latest Dyne Therapeutics (DYN) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Dyne Therapeutics (DYN)
Order type
Buy in
Order amount
Est. shares
0 shares
Dyne Therapeutics (DYN) Earnings per Share (EPS) History
Signup for full accessBrowse free
Dyne Therapeutics (DYN) Latest Earnings
The value each DYN share was expected to gain vs. the value each share gained.
Dyne Therapeutics (DYN) reported its most recent earnings on Nov 5, 2025 for Q3 2025, posting earnings per share (EPS) of -$0.76. This exceeded analysts' expectations of -$0.83 by 8.43%, marking a Beat.
For comparison, Dyne Therapeutics reported EPS of -$0.96 in the same quarter last year.
The company is expected to announce its next earnings report on 02/26/2026, with analysts projecting an EPS of -$0.77.
Dyne Therapeutics (DYN) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
|---|---|---|---|---|
Q4 2025Feb 27, 2026 | -$0.77 | Next earnings call Feb. 26, 2026 | ||
Q3 2025Nov 5, 2025 | -$0.83 | -$0.76 | -8.43% | |
Q2 2025Jul 28, 2025 | -$0.96 | -$0.97 | +1.04% | |
Q1 2025May 8, 2025 | -$0.84 | -$1.05 | +25.00% | |
Q4 2024Feb 27, 2025 | -$0.75 | -$0.88 | +17.33% | |
Dyne Therapeutics (DYN) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Dyne Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| Nov 5, 2025 | — | — | — |
| Jul 28, 2025 | — | — | — |
| May 8, 2025 | — | — | — |
| Feb 27, 2025 | — | — | — |
Dyne Therapeutics (DYN) Earnings FAQs
Dyne Therapeutics (DYN) last reported earnings on Nov 5, 2025 for Q3 2025, posting an EPS of -$0.76, which Beat the estimate of -$0.83 by 8.43%.
For Q3 2025, Dyne Therapeutics (DYN) reported an EPS of -$0.76, exceeding analysts' estimate of -$0.83 by 8.43%.
For Q3 2025, Dyne Therapeutics (DYN) Beat expectations with an actual EPS of -$0.76 vs. an estimated EPS of -$0.83.
Following the last earnings report on Nov 5, 2025, Dyne Therapeutics (DYN)'s stock price moved — from — to —.
The next Dyne Therapeutics (DYN) earnings call is scheduled for Feb. 26, 2026, where executives will discuss financial results and outlook.